8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
May 4, 2026·SEC
Material company update
Feb 19, 2026·SEC
AMN Healthcare Services, Inc.(AMN)Earnings, Financials & Key Ratios
AMN•NYSE
Price updated Jun 19, 2026
AboutAMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, telehealth, credentialing, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, and Merritt Hawkins, as well as AMN Revenue Cycle Solutions and AMN Language Services. The company was founded in 1985 and is based in Dallas, Texas.Show more
- Revenue$2.73B-8.5%
- EBITDA$190M+166.9%
- Net Income-$96M+34.9%
- EPS (Diluted)-2.48+35.6%
- Gross Margin28.35%-8.0%
- EBITDA Margin6.95%+191.6%
- Operating Margin1.21%+135.3%
- Net Margin-3.5%+28.8%
- ROE-14.19%+25.8%
AMN Key Insights
AMN Healthcare Services, Inc. (AMN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 94 (top 6%)
- ✓Efficient asset utilization: 1.3x turnover
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when AMN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AMN Price & Volume
AMN Healthcare Services, Inc. (AMN) stock price & volume — 10-year historical chart
Loading chart...
AMN Growth Metrics
AMN Healthcare Services, Inc. (AMN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.44%
5 Years2.67%
3 Years-19.55%
TTM19.87%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM80.38%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM79.9%
Return on Capital
10 Years15.43%
5 Years13.39%
3 Years4.25%
Last Year1.96%
AMN Recent Earnings
AMN Healthcare Services, Inc. (AMN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$2.10+31.3%
$1.60
Rev
$1.4B+11.7%
$1.2B
Q1 2026
Feb 19, 2026Metric
Actual
Est
EPS
$0.22+0.0%
$0.22
Rev
$748M+3.4%
$724M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.39+105.3%
$0.19
Rev
$634M-12.3%
$723M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.30+76.5%
$0.17
Rev
$658M+2.9%
$640M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $2.10vs $1.60+31.3% | $1.4Bvs $1.2B+11.7% |
| Q1 2026 | Feb 19, 2026 | $0.22vs $0.22+0.0% | $748Mvs $724M+3.4% |
| Q4 2025 | Nov 6, 2025 | $0.39vs $0.19+105.3% | $634Mvs $723M-12.3% |
| Q3 2025 | Aug 7, 2025 | $0.30vs $0.17+76.5% | $658Mvs $640M+2.9% |
Based on last 12 quarters of dataView full earnings history →
AMN Peer Comparison
AMN Healthcare Services, Inc. (AMN) competitors in Healthcare staffing and facility services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CHE | 5.97B | 436.27 | 23.68 | 4.06% | 10.23% | 25.33% | 0.16 | |
 CCRN | 425.82M | 13.17 | -4.49 | -21.56% | -9.84% | -27.1% | 0.01 | |
 TBI | 203.41M | 6.70 | -4.16 | 3.1% | -4.29% | -18.74% | 0.62 | |
 HCSG | 1.64B | 22.94 | 28.32 | 7.08% | 3.21% | 11.83% | 0.05 | |
 MMS | 2.93B | 55.74 | 10.12 | 2.36% | 7.02% | 21.75% | 0.86 | |
 OPCH | 3.44B | 21.99 | 17.32 | 13.03% | 3.64% | 15.28% | ||
 ADUS | 1.76B | 94.23 | 18.09 | 23.21% | 6.89% | 9.34% | 0.19 | |
 ENSG | 8.98B | 153.65 | 26.31 | 18.72% | 6.89% | 16.61% | 1.86 |
Compare AMN vs Peers
AMN Healthcare Services, Inc. (AMN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AMN Income Statement
AMN Healthcare Services, Inc. (AMN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 1.99B | 2.14B | 2.22B | 2.39B | 3.98B | 5.24B | 3.79B | 2.98B | 2.73B | 3.42B |
Revenue Growth % | 4.53% | 7.42% | 4.03% | 7.72% | 66.45% | 31.6% | -27.73% | -21.26% | -8.49% | 19.87% |
Cost of Goods Sold | 1.34B | 1.44B | 1.48B | 1.6B | 2.67B | 3.53B | 2.54B | 2.06B | 1.96B | 2.47B |
COGS % of Revenue | 67.59% | 67.4% | 66.54% | 66.92% | 67.13% | 67.26% | 67.02% | 69.19% | 71.65% | - |
Gross Profit | 644.42M▲ 0% | 696.38M▲ 8.1% | 743.47M▲ 6.8% | 791.78M▲ 6.5% | 1.31B▲ 65.4% | 1.72B▲ 31.1% | 1.25B▼ 27.2% | 919.38M▼ 26.4% | 774.06M▼ 15.8% | 944.77M▲ 0% |
Gross Margin % | 32.41% | 32.6% | 33.46% | 33.08% | 32.87% | 32.74% | 32.98% | 30.81% | 28.35% | 27.63% |
Gross Profit Growth % | 3.98% | 8.06% | 6.76% | 6.5% | 65.4% | 31.08% | -27.21% | -26.43% | -15.81% | - |
Operating Expenses | 431.98M | 493.56M | 566.55M | 642.51M | 831.6M | 1.07B | 911.15M | 1.02B | 740.89M | 934.72M |
OpEx % of Revenue | 21.72% | 23.11% | 25.5% | 26.84% | 20.87% | 20.4% | 24.05% | 34.25% | 27.13% | - |
Selling, General & Admin | 399.7M | 452.32M | 508.03M | 549.75M | 730.45M | 936.58M | 756.24M | 632.49M | 593.02M | 663.72M |
SG&A % of Revenue | 20.1% | 21.18% | 22.86% | 22.97% | 18.33% | 17.86% | 19.96% | 21.2% | 21.72% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 32.28M | 41.24M | 58.52M | 92.77M | 101.15M | 133.01M | 154.91M | 389.56M | 147.87M | 4M |
Operating Income | 212.44M▲ 0% | 202.83M▼ 4.5% | 176.91M▼ 12.8% | 149.26M▼ 15.6% | 478M▲ 220.2% | 647.1M▲ 35.4% | 338.43M▼ 47.7% | -102.67M▼ 130.3% | 33.17M▲ 132.3% | 10.05M▲ 0% |
Operating Margin % | 10.68% | 9.5% | 7.96% | 6.24% | 12% | 12.34% | 8.93% | -3.44% | 1.21% | 0.29% |
Operating Income Growth % | 10.86% | -4.52% | -12.78% | -15.63% | 220.23% | 35.38% | -47.7% | -130.34% | 132.3% | - |
EBITDA | 244.72M | 244.06M | 235.44M | 243.45M | 581.7M | 784.21M | 499.36M | 71.11M | 189.77M | 126.8M |
EBITDA Margin % | 12.31% | 11.43% | 10.6% | 10.17% | 14.6% | 14.96% | 13.18% | 2.38% | 6.95% | 3.71% |
EBITDA Growth % | 10.61% | -0.27% | -3.54% | 3.41% | 138.94% | 34.82% | -36.32% | -85.76% | 166.88% | 225.05% |
D&A (Non-Cash Add-back) | 32.28M | 41.24M | 58.52M | 94.19M | 103.7M | 137.11M | 160.93M | 173.78M | 156.6M | 116.74M |
EBIT | 212.44M | 202.83M | 176.91M | 149.26M | 478M | 647.1M | 338.43M | -102.67M | -55.47M | 49.19M |
Net Interest Income | -19.68M | -16.14M | -28.43M | -57.74M | -34.08M | -40.4M | -54.14M | -69.9M | -45.59M | -39.98M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 19.68M | 16.14M | 28.43M | 57.74M | 34.08M | 40.4M | 54.14M | 69.9M | 45.59M | 39.98M |
Other Income/Expense | -19.68M | -16.14M | -28.43M | -57.74M | -34.08M | -40.4M | -54.14M | -69.9M | -134.23M | -841K |
Pretax Income | 192.76M▲ 0% | 186.69M▼ 3.2% | 148.49M▼ 20.5% | 91.52M▼ 38.4% | 443.92M▲ 385.0% | 606.7M▲ 36.7% | 284.29M▼ 53.1% | -172.57M▼ 160.7% | -101.06M▲ 41.4% | 9.21M▲ 0% |
Pretax Margin % | 9.69% | 8.74% | 6.68% | 3.82% | 11.14% | 11.57% | 7.5% | -5.78% | -3.7% | 0.27% |
Income Tax | 60.2M | 44.94M | 34.5M | 20.86M | 116.53M | 162.65M | 73.61M | -25.59M | -5.36M | 41.66M |
Effective Tax Rate % | 31.23% | 24.07% | 23.23% | 22.79% | 26.25% | 26.81% | 25.89% | 14.83% | 5.3% | 452.15% |
Net Income | 132.56M▲ 0% | 141.74M▲ 6.9% | 113.99M▼ 19.6% | 70.67M▼ 38.0% | 327.39M▲ 363.3% | 444.05M▲ 35.6% | 210.68M▼ 52.6% | -146.98M▼ 169.8% | -95.7M▲ 34.9% | -32.44M▲ 0% |
Net Margin % | 6.67% | 6.64% | 5.13% | 2.95% | 8.22% | 8.47% | 5.56% | -4.93% | -3.5% | -0.95% |
Net Income Growth % | 25.25% | 6.93% | -19.58% | -38.01% | 363.3% | 35.63% | -52.56% | -169.76% | 34.89% | 80.38% |
Net Income (Continuing) | 132.56M | 141.74M | 113.99M | 70.67M | 327.39M | 444.05M | 210.68M | -146.98M | -95.7M | -32.44M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 2.68▲ 0% | 2.91▲ 8.6% | 2.40▼ 17.5% | 1.48▼ 38.3% | 6.81▲ 360.1% | 9.90▲ 45.4% | 5.36▼ 45.9% | -3.85▼ 171.8% | -2.48▲ 35.6% | -0.83▲ 0% |
EPS Growth % | 24.65% | 8.58% | -17.53% | -38.33% | 360.14% | 45.37% | -45.86% | -171.83% | 35.58% | 79.9% |
EPS (Basic) | 2.77 | 2.99 | 2.44 | 1.49 | 6.87 | 9.96 | 5.38 | -3.85 | -2.48 | - |
Diluted Shares Outstanding | 49.43M | 48.67M | 47.59M | 47.69M | 48.05M | 44.87M | 39.34M | 38.19M | 38.52M | 39.12M |
Basic Shares Outstanding | 47.81M | 47.37M | 46.7M | 47.42M | 47.69M | 44.59M | 39.17M | 38.19M | 38.52M | 38.9M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
AMN Balance Sheet
AMN Healthcare Services, Inc. (AMN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 474.15M | 482.17M | 560.5M | 533.74M | 1.35B | 1.09B | 841.68M | 594.91M | 545.38M | 1.14B |
Cash & Short-Term Investments | 15.15M | 13.86M | 82.98M | 29.21M | 180.93M | 64.52M | 32.94M | 10.65M | 33.97M | 560.74M |
Cash Only | 15.15M | 13.86M | 82.98M | 29.21M | 180.93M | 64.52M | 32.94M | 10.65M | 33.97M | 560.74M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 407.41M | 416.81M | 431.38M | 450.08M | 1.03B | 953.25M | 746.54M | 519.98M | 439.11M | 442.17M |
Days Sales Outstanding | 74.78 | 71.22 | 70.86 | 68.63 | 94.25 | 66.36 | 71.91 | 63.61 | 58.7 | 47.54 |
Inventory | 57.91M | 39.54M | 0 | 38.85M | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | 15.73 | 10.02 | - | 8.85 | - | - | - | - | - | - |
Other Current Assets | 35.09M | 39.09M | 34.46M | 1.96M | 66.83M | 57.16M | 40.32M | 41.77M | 72.3M | 107.77M |
Total Non-Current Assets | 779.8M | 1.01B | 1.37B | 1.82B | 1.78B | 1.79B | 2.08B | 1.82B | 1.55B | 1.47B |
Property, Plant & Equipment | 73.43M | 90.42M | 194.7M | 193.91M | 154.88M | 165.54M | 225.93M | 218.38M | 136.36M | 151.72M |
Fixed Asset Turnover | 27.08x | 23.62x | 11.41x | 12.34x | 25.72x | 31.67x | 16.77x | 13.66x | 20.02x | 21.00x |
Goodwill | 340.6M | 438.51M | 595.55M | 864.49M | 892.34M | 935.36M | 1.11B | 897.46M | 755.81M | 755.81M |
Intangible Assets | 227.1M | 326.15M | 398.47M | 564.91M | 514.46M | 476.83M | 474.13M | 381.36M | 283.53M | 265.58M |
Long-Term Investments | -27.04M | -27.33M | 0 | 0 | 0 | 0 | 0 | 0 | 45.61M | 91.42M |
Other Non-Current Assets | 138.68M | 155.48M | 182.42M | 129.26M | 221.15M | 216.97M | 271.1M | 297.78M | 282.55M | 237.72M |
Total Assets | 1.25B▲ 0% | 1.49B▲ 19.0% | 1.93B▲ 29.4% | 2.35B▲ 21.8% | 3.13B▲ 33.1% | 2.89B▼ 7.8% | 2.92B▲ 1.2% | 2.42B▼ 17.4% | 2.09B▼ 13.3% | 2.6B▲ 0% |
Asset Turnover | 1.59x | 1.43x | 1.15x | 1.02x | 1.27x | 1.82x | 1.30x | 1.24x | 1.30x | 1.51x |
Asset Growth % | 5.65% | 19.04% | 29.4% | 21.84% | 33.07% | -7.78% | 1.25% | -17.39% | -13.31% | -44.58% |
Total Current Liabilities | 265.27M | 307.27M | 378.11M | 422.96M | 969.39M | 857.93M | 656.12M | 545.78M | 577.61M | 1.04B |
Accounts Payable | 73.21M | 82.43M | 102.55M | 107.45M | 339.01M | 373.32M | 177.11M | 100.92M | 84.94M | 197.38M |
Days Payables Outstanding | 19.88 | 20.9 | 25.31 | 24.48 | 46.26 | 38.64 | 25.45 | 17.84 | 15.85 | 17.45 |
Short-Term Debt | 0 | 0 | 0 | 4.69M | 0 | 0 | 0 | 0 | 0 | 5.8M |
Deferred Revenue (Current) | 8.38M | 12.37M | 11.79M | 11M | 157.05M | 33.29M | 20.01M | 66.36M | 0 | 119.78M |
Other Current Liabilities | 62.26M | 88.79M | 149.71M | 167.37M | 250.48M | 251.95M | 223.39M | 237.53M | 486.66M | 518.55M |
Current Ratio | 1.79x | 1.57x | 1.48x | 1.26x | 1.39x | 1.27x | 1.28x | 1.09x | 0.94x | 1.09x |
Quick Ratio | 1.57x | 1.44x | 1.48x | 1.17x | 1.39x | 1.27x | 1.28x | 1.09x | 0.94x | 1.09x |
Cash Conversion Cycle | 70.63 | 60.35 | - | 53 | - | - | - | - | - | 30.09 |
Total Non-Current Liabilities | 426.16M | 546.46M | 816.8M | 1.11B | 1B | 986.78M | 1.44B | 1.16B | 874.39M | 847.38M |
Long-Term Debt | 319.84M | 440.61M | 617.16M | 857.96M | 842.32M | 843.5M | 1.3B | 1.06B | 767.05M | 742.49M |
Capital Lease Obligations | 0 | 0 | 91.21M | 77.8M | 13.36M | 9.36M | 37.6M | 35.73M | 30.14M | 123.79M |
Deferred Tax Liabilities | 27.04M | 27.33M | 46.62M | 0 | 47.81M | 22.71M | 23.35M | 0 | 0 | 0 |
Other Non-Current Liabilities | 106.31M | 77.66M | 61.81M | 107.91M | 96.99M | 111.21M | 71.38M | 71.72M | 77.19M | 76.26M |
Total Liabilities | 691.43M | 853.73M | 1.19B | 1.53B | 1.97B | 1.84B | 2.09B | 1.71B | 1.45B | 1.89B |
Total Debt | 319.84M | 440.61M | 722.31M | 955.48M | 867.07M | 860.96M | 1.35B | 1.1B | 803.2M | 776.92M |
Net Debt | 304.7M | 426.75M | 639.33M | 926.27M | 686.14M | 796.43M | 1.32B | 1.09B | 769.23M | 216.18M |
Debt / Equity | 0.57x | 0.69x | 0.98x | 1.17x | 0.75x | 0.82x | 1.62x | 1.55x | 1.25x | 1.09x |
Debt / EBITDA | 1.31x | 1.81x | 3.07x | 3.92x | 1.49x | 1.10x | 2.70x | 15.44x | 4.23x | 6.13x |
Net Debt / EBITDA | 1.25x | 1.75x | 2.72x | 3.80x | 1.18x | 1.02x | 2.64x | 15.29x | 4.05x | 1.70x |
Interest Coverage | 10.80x | 12.56x | 6.22x | 2.59x | 14.03x | 16.02x | 6.25x | -1.47x | -1.22x | 1.23x |
Total Equity | 562.53M▲ 0% | 638.99M▲ 13.6% | 736.74M▲ 15.3% | 819.68M▲ 11.3% | 1.16B▲ 41.8% | 1.04B▼ 10.2% | 831.26M▼ 20.3% | 706.62M▼ 15.0% | 642.11M▼ 9.1% | 712.81M▲ 0% |
Equity Growth % | 25.18% | 13.59% | 15.3% | 11.26% | 41.77% | -10.19% | -20.35% | -14.99% | -9.13% | -67.8% |
Book Value per Share | 11.38 | 13.13 | 15.48 | 17.19 | 24.19 | 23.26 | 21.13 | 18.50 | 16.67 | 18.22 |
Total Shareholders' Equity | 562.53M | 638.99M | 736.74M | 819.68M | 1.16B | 1.04B | 831.26M | 706.62M | 642.11M | 712.81M |
Common Stock | 484K | 488K | 493K | 496K | 498K | 501K | 504K | 507K | 511K | 513K |
Retained Earnings | 142.23M | 286.06M | 400.05M | 469.56M | 796.95M | 1.24B | 1.45B | 1.3B | 1.21B | 1.27B |
Treasury Stock | -33.42M | -100.44M | -119.14M | -119.14M | -121.83M | -698.6M | -1.13B | -1.13B | -1.13B | -1.13B |
Accumulated OCI | -112K | 151K | 152K | 40K | -295K | -939K | -423K | -11K | 298K | 113K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AMN Cash Flow Statement
AMN Healthcare Services, Inc. (AMN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 115.26M | 226.99M | 224.86M | 256.83M | 305.36M | 653.73M | 372.17M | 320.42M | 269.46M | 739.24M |
Operating CF Margin % | 5.8% | 10.63% | 10.12% | 10.73% | 7.66% | 12.47% | 9.82% | 10.74% | 9.87% | - |
Operating CF Growth % | -12.58% | 96.94% | -0.94% | 14.21% | 18.9% | 114.09% | -43.07% | -13.9% | -15.9% | 423.63% |
Net Income | 132.56M | 141.74M | 113.99M | 70.67M | 327.39M | 444.05M | 210.68M | -146.98M | -95.7M | -32.44M |
Depreciation & Amortization | 32.28M | 41.24M | 58.52M | 94.19M | 103.7M | 137.11M | 160.93M | 173.78M | 156.6M | 116.74M |
Stock-Based Compensation | 10.24M | 10.81M | 16.24M | 20.46M | 25.22M | 30.07M | 18.02M | 23.32M | 30.68M | 21.3M |
Deferred Taxes | 5.61M | -667K | 913K | -21.63M | -16.29M | -24.61M | -12.93M | -51.07M | -19.55M | -30.6M |
Other Non-Cash Items | 12.85M | 2.25M | 16.22M | 26.01M | 8.84M | 67.68M | 45.6M | 235.46M | 96.39M | 248.33M |
Working Capital Changes | -78.27M | 31.61M | 18.98M | 67.13M | -143.49M | -558K | -50.13M | 85.91M | 101.03M | 478.08M |
Change in Receivables | -10.64M | -10.58M | 5.71M | -8.61M | -585.27M | 20.04M | 224.85M | 219.44M | 74.75M | 41.69M |
Change in Inventory | -32.63M | 14.56M | -1.93M | -5.56M | -256.12M | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -7.86M | 17.15M | 1.93M | 5.56M | 256.12M | 0 | 0 | 0 | 0 | 19.06M |
Cash from Investing | -33.45M | -279.34M | -291.82M | -538.17M | -107.4M | -170.71M | -412.49M | -79.94M | 4.3M | 22.84M |
Capital Expenditures | -26.53M | -36.39M | -36.46M | -39.1M | -53.66M | -75.83M | -103.69M | -80.89M | -35.63M | -32.9M |
CapEx % of Revenue | 1.33% | 1.7% | 1.64% | 1.63% | 1.35% | 1.45% | 2.74% | 2.71% | 1.3% | 0.96% |
Acquisitions | -1.5M | -217.36M | -247.91M | -476.43M | -41.26M | -69.5M | -292.1M | 0 | 65.28M | -41K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -8.62M | -10.67M | -13.29M | -7.66M | -8.99M | -26.61M | -26.6M | -6.76M | 22K | 68.53M |
Cash from Financing | -77.19M | 37.51M | 136.6M | 211.49M | -34.9M | -591.87M | 10.73M | -259.45M | -295.89M | -261.82M |
Debt Issued (Net) | -44.06M | 120M | 180M | 240.54M | -21.88M | 0 | 459.7M | -250M | -285M | -250M |
Equity Issued (Net) | -20.16M | -67.01M | -18.7M | -6.93M | -2.69M | -576.77M | -424.74M | 0 | 0 | -492K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -20.16M | -67.01M | -18.7M | -6.93M | -2.69M | -576.77M | -424.74M | 0 | 0 | -492K |
Other Financing | -12.97M | -15.48M | -24.7M | -22.13M | -10.33M | -15.1M | -24.23M | -9.45M | -10.89M | -11.32M |
Net Change in Cash | 4.53M▲ 0% | -14.57M▼ 422.0% | 69.64M▲ 578.0% | -69.97M▼ 200.5% | 162.72M▲ 332.6% | -108.84M▼ 166.9% | -29.6M▲ 72.8% | -18.97M▲ 35.9% | -22.13M▼ 16.7% | 513.81M▲ 0% |
Free Cash Flow | 88.73M▲ 0% | 190.61M▲ 114.8% | 188.4M▼ 1.2% | 217.72M▲ 15.6% | 251.69M▲ 15.6% | 572.81M▲ 127.6% | 266.78M▼ 53.4% | 239.53M▼ 10.2% | 233.83M▼ 2.4% | 706.34M▲ 0% |
FCF Margin % | 4.46% | 8.92% | 8.48% | 9.1% | 6.32% | 10.92% | 7.04% | 8.03% | 8.56% | 20.66% |
FCF Growth % | -19.26% | 114.81% | -1.16% | 15.56% | 15.6% | 127.58% | -53.43% | -10.21% | -2.38% | 172.74% |
FCF per Share | 1.80 | 3.92 | 3.96 | 4.57 | 5.24 | 12.77 | 6.78 | 6.27 | 6.07 | 18.06 |
FCF Conversion (FCF/Net Income) | 0.87x | 1.60x | 1.97x | 3.63x | 0.93x | 1.47x | 1.77x | -2.18x | -2.82x | -21.77x |
Interest Paid | 17.94M | 21.28M | 23.73M | 22.65M | 38.09M | 37.52M | 48.1M | 61.03M | 45.11M | 42.17M |
Taxes Paid | 73.75M | 30.59M | 37.75M | 46.26M | 106.38M | 213.81M | 78.26M | 28.15M | 7.85M | 8.61M |
AMN Key Ratios
AMN Healthcare Services, Inc. (AMN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 26.2% | 23.59% | 16.57% | 9.08% | 33.04% | 40.26% | 22.47% | -19.11% | -14.19% | -4.98% |
Return on Invested Capital (ROIC) | 19.09% | 15.74% | 10.87% | 7.17% | 19.95% | 26.32% | 12.73% | -3.91% | 1.55% | 0.56% |
Gross Margin | 32.41% | 32.6% | 33.46% | 33.08% | 32.87% | 32.74% | 32.98% | 30.81% | 28.35% | 27.63% |
Net Margin | 6.67% | 6.64% | 5.13% | 2.95% | 8.22% | 8.47% | 5.56% | -4.93% | -3.5% | -0.95% |
Debt / Equity | 0.57x | 0.69x | 0.98x | 1.17x | 0.75x | 0.82x | 1.62x | 1.55x | 1.25x | 1.09x |
Interest Coverage | 10.80x | 12.56x | 6.22x | 2.59x | 14.03x | 16.02x | 6.25x | -1.47x | -1.22x | 1.23x |
FCF Conversion | 0.87x | 1.60x | 1.97x | 3.63x | 0.93x | 1.47x | 1.77x | -2.18x | -2.82x | -21.77x |
Revenue Growth | 4.53% | 7.42% | 4.03% | 7.72% | 66.45% | 31.6% | -27.73% | -21.26% | -8.49% | 19.87% |
Related:AMN Dividend History·AMN Revenue History·AMN Price History·AMN P/E History·AMN Financial Ratios·AMN Institutional Holders
AMN SEC Filings & Documents
AMN Healthcare Services, Inc. (AMN) SEC filings — annual & quarterly reports (10-K, 10-Q)
AMN Frequently Asked Questions
AMN Healthcare Services, Inc. (AMN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
AMN Healthcare Services, Inc. (AMN) reported $3.42B in revenue for fiscal year 2025. This represents a 1382% increase from $230.8M in 2000.
AMN Healthcare Services, Inc. (AMN) saw revenue decline by 8.5% over the past year.
AMN Healthcare Services, Inc. (AMN) reported a net loss of $32.4M for fiscal year 2025.
Dividend & Returns
AMN Healthcare Services, Inc. (AMN) has a return on equity (ROE) of -14.2%. Negative ROE indicates the company is unprofitable.
AMN Healthcare Services, Inc. (AMN) generated $706.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.